Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hart, Marian D
NCT05231668: Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)	Terminated	1	16	Europe, Canada, US, RoW	SAR439459, Placebo	Sanofi	Osteogenesis Imperfecta	11/24	11/24
NCT06719531: SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients with Type 1 and Type 2 Diabetes	Not yet recruiting	N/A	1500	US	Continuous Glucose Monitoring	Medtronic Diabetes	Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus	12/25	12/25
LINC6, NCT05382156: Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome	Active, not recruiting	N/A	206	Europe, US	Osilodrostat, Isturisa	RECORDATI GROUP	Endogenous Cushing's Syndrome	06/27	08/27
Bergwitz, Clemens
NCT06525636: A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia	Recruiting	1/2	24	Europe, US	KK8123	Kyowa Kirin, Inc.	X-linked Hypophosphatemia	02/28	05/28
NCT03771105: The Impact of Phosphate Metabolism on Healthy Aging	Suspended	1	30	US	phosphate	Yale University, National Center for Advancing Translational Sciences (NCATS)	Hypophosphatemia, Rickets, Hypercalciuria, XLH, HHRH	08/24	08/24
NCT05231668: Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)	Terminated	1	16	Europe, Canada, US, RoW	SAR439459, Placebo	Sanofi	Osteogenesis Imperfecta	11/24	11/24